Skip to main content

Stendra FDA Approval History

FDA Approved: Yes (First approved April 27, 2012)
Brand name: Stendra
Generic name: avanafil
Dosage form: Tablets
Company: Vivus, Inc.
Treatment for: Erectile Dysfunction

Stendra (avanafil) is a phosphodiesterase type 5 (PDE5) inhibitor for the treatment of erectile dysfunction (ED).

Development timeline for Stendra

Apr 27, 2012Approval FDA Approves Stendra for Erectile Dysfunction
Sep  2, 2011VIVUS Announces FDA Acceptance of Avanafil New Drug Application for Treatment of Erectile Dysfunction
Jun 30, 2011VIVUS Submits New Drug Application for Avanafil for the Treatment of Erectile Dysfunction

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.